Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 14 recruiting now early-phase tilt

Aortic Stenosis: early-phase trial registry

14 of 27 indexed Aortic Stenosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #598 of 28,707 conditions by registered trial count.

27 US clinical trials · 14 currently recruiting · #598 of 28,707 conditions by registered trial count

Aortic Stenosis: 27 US clinical trials tracked, 14 recruiting.

Aortic Stenosis is the subject of 27 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Edwards Lifesciences, running 4 of these trials.

Enrollment posture brief

Registry condition aortic-stenosis

OPEN 14 | RECR 52% | LATE 0 | EARLY 3 | RANK #598 | SPON 4

Nearest open-share peer: Colorectal Carcinoma (52% recruiting · 54 trials)

Alopecia Areata55.6%Aortic Stenosis (this)52%Acute Ischemic Stroke44.4%Adenocarcinoma25.9%Acne22.2%
Open-enrollment share among volume-matched conditions near Aortic Stenosis

Aortic Stenosis lists 14 open slots (52% of 27 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Aortic Stenosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Aortic Stenosis is recruiting above its size-band peers.

    14 of 27 indexed trials (51.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Aortic Stenosis trials is spread across many organizations.

    Edwards Lifesciences accounts for 4 of 27 trials (14.8%). 20 distinct sponsors appear on at least one study for this condition label.

  3. Typical Aortic Stenosis enrolment sits around 225 participants.

    Median target enrolment is 225 among the 27 trials that report a genuine target (sentinel values excluded). 8 of those (29.6%) plan for fewer than 100 participants.

  4. Aortic Stenosis splits between interventional and observational designs.

    17 interventional and 10 observational studies make up this index (63% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 21

Open and recent trials

27 total, page 1 of 1

RECRUITING 5,000 participants

Study of the Progression of Chronic Cardiovascular Conditions

Prolaio

NCT07420907

RECRUITING NA 4,000 participants

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

University of British Columbia

NCT04634240

RECRUITING 2,000 participants

AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

Mayo Clinic

NCT06580158

RECRUITING Phase 2 502 participants

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Novartis Pharmaceuticals

NCT05646381

RECRUITING Phase 1 300 participants

The HALT Biomarker Study

Massachusetts General Hospital

NCT04552275

RECRUITING 225 participants

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Medtronic Cardiovascular

NCT06777368

RECRUITING 200 participants

Loss of Y Chromosome in Aortic Stenosis

University of Virginia

NCT06595407

RECRUITING 200 participants

Comparative Imaging Assessment of Valvular Heart Disease

The Cleveland Clinic

NCT04126018

RECRUITING 200 participants

Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease

The Cleveland Clinic

NCT06780241

RECRUITING NA 125 participants

PARTNER 3 Trial - Aortic Valve-in-Valve

Edwards Lifesciences

NCT03003299

RECRUITING NA 100 participants

Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure

University of Tennessee Graduate School of Medicine

NCT07205068

RECRUITING 50 participants

Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry

Kansas City Heart Rhythm Research Foundation

NCT06055751

RECRUITING NA 25 participants

Evaluating Infrasonic Hemodynography

Scripps Health

NCT04636892

RECRUITING NA 6 participants

Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis

Dermed Diagnostics

NCT07230964

ACTIVE NOT RECRUITING 15,000 participants

Genomic Investigation of Cardiovascular Diseases

Scripps Translational Science Institute

NCT00722748

ACTIVE NOT RECRUITING NA 1,948 participants

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Boston Scientific Corporation

NCT03735667

ACTIVE NOT RECRUITING NA 1,312 participants

PERIGON Pivotal Trial

Medtronic Cardiac Surgery

NCT02088554

ACTIVE NOT RECRUITING NA 1,000 participants

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Edwards Lifesciences

NCT02675114

ACTIVE NOT RECRUITING NA 777 participants

ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

Edwards Lifesciences

NCT01757665

ACTIVE NOT RECRUITING NA 15 participants

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

Anteris Technologies

NCT05712161

COMPLETED NA 1,822 participants

PARTNER II Trial: S3iCAP

Edwards Lifesciences

NCT02687035

COMPLETED NA 277 participants

Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis

Medstar Health Research Institute

NCT02628899

COMPLETED NA 241 participants

Medtronic CoreValve Evolut R U.S. Clinical Study

Medtronic Cardiovascular

NCT02207569

COMPLETED 49 participants

Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR)

University of British Columbia

NCT04827238

COMPLETED 31 participants

Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions

University of Colorado, Denver

NCT02545790

COMPLETED NA 8 participants

The ShortCut™ Continued Access Study Protocol

Pi-cardia

NCT06211296

COMPLETED Early Phase 1 4 participants

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

Mayo Clinic

NCT04899180

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Named interventions

Most-linked intervention names on Aortic Stenosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

99mTc-PYP Drug
1 trials
Shortcut Device
1 trials
Standardized Invasive Hemodynamics Diagnostic test
1 trials
Transfemoral TAVR Device
1 trials
SAPIEN S3 valve Device
1 trials
Serology Biological
1 trials
CoreValve Evolut R TAVR system Device
1 trials
SAVR Procedure
1 trials

US sites by state

Facility locations filed on Aortic Stenosis trials. A trial with sites in several states counts in each.

California 14 trials
Florida 10 trials
Georgia 8 trials
Arizona 8 trials
Michigan 7 trials
Massachusetts 7 trials
Indiana 7 trials
Illinois 7 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Aortic Stenosis page

27 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Aortic Stenosis condition card totals 27 registered trials; most-linked intervention 99mTc-PYP; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.